Shots: The P-III COMET-ICE trial involves assessing sotrovimab vs PBO in 1057 patients with mild-to-moderate COVID-19 The trial meets its 1EPs i.e. a 79% reduction in hospitalization for >24hrs. or […]readmore
Tags : COMET-ICE trial
Shots: The IDMC has recommended stopping the enrollment in the P-III COMET-ICE trial due to evidence of profound efficacy. The study involves assessing VIR-7831 (GSK4182136) vs PBO in 583 patients […]readmore